The most talked-about and market-moving market research calls on Wall Street are now in one place. Here are today’s research calls that investors should know about, compiled by The Fly.
Top 5 updates:
-
JPMorgan updated Toll Brothers (TOL) to Overweight from Neutral with a price target of $161, up from $138. The company finds Toll’s valuation attractive given the company’s “solidly above average” gross and operating margins.
-
JPMorgan updated Toast (TOST) to Overweight from Neutral with an unchanged price target of $43. The company sees potential for improvement in estimates if the exchange is regulated.
-
Citizens JMP updated accelerator (ARX) will outperform the market with a $20 price target. Stock weakness since the company’s initial public offering in July has been driven by “overblown fear” related to related-party dealings, the company tells investors in a research note.
-
Improved colliers UMH Properties (UMH) to Buy from Neutral with a price target of $17, up from $16. The firm says the manufactured housing sector continues to benefit from elevated multiples given its “defensive characteristics” and “resilience to broader economic challenges.”
-
Raymond James updated Descartes Systems (DSGX) will outperform the market with a price target of $118. The stock now trades near the bottom of its 10-year EBITDA multiple range, positioning the stock well for a potential freight market recovery, says Raymond James.
Top 5 Downgrades:
-
JPMorgan downgraded its rating PayPal (PYPL) to Neutral from Overweight with a price target of $70, down from $85. The firm considers that 2026 is a “year of execution and investment” for the company.
-
Goldman Sachs discounted m2 (SQM) to Neutral from Buy with a price target of $63, up from $45. The stock, after rising 80% so far this year, has outpaced the company’s fundamentals, the company tells investors in a research note.
-
JPMorgan downgraded its rating Lennar (LEN) to Underweight from Neutral with a price target of $115, down from $118. The firm maintains a cautious stance on the homebuilding sector for 2026.
-
Goldman Sachs discounted halozyme (HALO) to sell from Neutral with a price target of $56. The current valuation implies a terminal value assuming approximately $34 billion in product revenue from new partners by 2041, a level that appears achievable only in optimistic scenarios despite the recent acquisition of Elektrofi, the company claims.
-
JPMorgan downgraded its rating Fiserv (FISV) to Neutral from Overweight with an unchanged price target of $85. The firm considers that 2026 is a “year of execution and investment” for the company.